Abstract
Sleep duration, sleep deprivation and the sleep-wake cycle are thought to play an important role in the generation of epileptic activity and may also influence seizure risk. Hence, people diagnosed with epilepsy are commonly asked to maintain consistent sleep routines. However, emerging evidence paints a more nuanced picture of the relationship between seizures and sleep, with bidirectional effects between changes in sleep and seizure risk in addition to modulation by sleep stages and transitions between stages. We conducted a longitudinal study investigating sleep parameters and self-reported seizure occurrence in an ambulatory at-home setting using mobile and wearable monitoring.
Forty-four subjects wore a Fitbit smartwatch for at least 28 days while reporting their seizure activity in a mobile app. Multiple sleep features were investigated, including duration, oversleep and undersleep, and sleep onset and offset times. Sleep features in participants with epilepsy were compared to a large (n=37921) representative population of Fitbit users, each with 28 days of data. For participants with at least 10 seizure days (n=29), sleep features were analysed for significant changes prior to seizure days.
A total of 3894 reported seizures (M = 88, SD = 130) and 17078 recorded sleep nights (M = 388, SD = 351) were included in the study. Participants with epilepsy slept an average of 2 hours longer than the average sleep duration within the general population. Just 1 of 29 participants showed a significant difference in sleep duration the night before seizure days compared to seizure-free days. However, 11 of 29 subjects showed significant differences between either their sleep onset (bed) or offset (wake) times prior to seizure occurrence. In contrast to previous studies, the current study found oversleeping was associated with a 20% increased seizure risk in the following 48h (p < 0.01), likely due to nocturnal seizures driving increased sleep durations.
Nocturnal seizures were associated with both significantly longer sleep durations and increased risk of a seizure occurring in the following 48h. Oversleeping only significantly contributed to increased seizure risk when participants were already in a high-risk (rather than baseline- or low-risk) state, according to their endogenous cycles of seizure likelihood.
Overall, the presented results demonstrated that day-to-day changes in sleep-duration had a minimal effect on reported seizures, while bed- and wake-times were more important for identifying seizure risk the following day. Oversleeping was linked to seizure occurrence, most likely due to nocturnal seizures driving oversleep. Wearables can be utilised to identify these sleep-seizure relationships and guide clinical recommendations or improve seizure forecasting algorithms.
Competing Interest Statement
RES, PJK, ESN, DRF and MJC have employment or a financial interest in Seer Medical Pty. Ltd. LDS is an employee of Alphabet Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
This research was funded by an NHMRC Investigator Grant (1178220), the Epilepsy Foundation of Americas My Seizure Gauge grant and the BioMedTech Horizons 3 program, an initiative of MTPConnect. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Research Ethics Committee (HREC) of The St Vincent's Hospital Melbourne, Australia, gave ethics approval (HREC 009/19) for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Excluding participants who did not consent to share their data publicly, deidentified data are available on Figshare (as DOI 10.6084/m9.figshare.20381298, to be made available upon publication).
https://figshare.com/articles/dataset/Sleep_and_seizures_in_epilepsy/20381298
Abbreviations
- IEDs
- interictal epileptiform discharges
